AMENDMENT TO SECURED CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • March 15th, 2019 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances)
This Amendment to Secured Convertible Promissory Note (this “Amendment”) is entered into as of March 13, 2019, by and among ILIAD RESEARCH AND TRADING, L.P., a Utah limited partnership (“Lender”), and HEMISPHERX BIOPHARMA, INC., a Delaware corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).
